IL102753A0 - Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines - Google Patents

Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines

Info

Publication number
IL102753A0
IL102753A0 IL102753A IL10275392A IL102753A0 IL 102753 A0 IL102753 A0 IL 102753A0 IL 102753 A IL102753 A IL 102753A IL 10275392 A IL10275392 A IL 10275392A IL 102753 A0 IL102753 A0 IL 102753A0
Authority
IL
Israel
Prior art keywords
animals
treating
mammary glands
recombinant cytokines
administering recombinant
Prior art date
Application number
IL102753A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL102753A0 publication Critical patent/IL102753A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL102753A 1991-08-07 1992-08-06 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines IL102753A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74127891A 1991-08-07 1991-08-07

Publications (1)

Publication Number Publication Date
IL102753A0 true IL102753A0 (en) 1993-01-31

Family

ID=24980081

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102753A IL102753A0 (en) 1991-08-07 1992-08-06 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines

Country Status (10)

Country Link
US (1) US5336488A (fr)
EP (1) EP0537437A3 (fr)
JP (1) JPH06107560A (fr)
AU (1) AU659179B2 (fr)
CA (1) CA2075328A1 (fr)
HU (1) HUT67071A (fr)
IL (1) IL102753A0 (fr)
NZ (1) NZ243850A (fr)
RU (1) RU2078580C1 (fr)
ZA (1) ZA925909B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0609739A1 (fr) * 1993-02-02 1994-08-10 American Cyanamid Company Méthode de renversement d'immunosuppresion en vaccins
US6929791B2 (en) 1998-07-16 2005-08-16 Institut Pasteur Peptides of IL-2 and derivatives thereof
US6168785B1 (en) * 1998-07-16 2001-01-02 Institut Pasteur Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
EP1944037B1 (fr) * 2005-09-27 2011-06-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Remede pour la mastite
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
RU2508072C1 (ru) * 2012-10-12 2014-02-27 Эдуард Васильевич Овчаренко Способ коррекции продуктивности получения молозива у коров
RU2536976C1 (ru) * 2013-12-26 2014-12-27 Государственное научное учреждение Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии Российской академии сельскохозяйственных наук (ГНУ ВНИВИПФиТ Россельхозакадемии) Способ лечения мастита у лактирующих овец
RU2683289C1 (ru) * 2018-04-16 2019-03-27 Государственное научное учреждение Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии Российской академии сельскохозяйственных наук (ГНУ ВНИВИПФиТ Россельхозакадемии) Способ профилактики мастита у лактирующих коров
RU2731476C1 (ru) * 2019-06-13 2020-09-03 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский ветеринарный институт патологии, фармокологии и терапии" (ФГБНУ "ВНИВИПФиТ") Способ профилактики мастита у лактирующих коров

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
CA1299103C (fr) * 1986-03-07 1992-04-21 Robert Joseph Collier Methode d'augmentation du parenchyme mammaire et ses compositions
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
DE68929566D1 (de) * 1988-05-13 2010-01-28 Amgen Inc Verfahren zur Isolierung und Reinigung von G-CSF
EP0405315B1 (fr) * 1989-06-30 1995-08-23 American Cyanamid Company Utilisation d'un agent activateur de la phagocytoce : LPS ou IL-2 pour fabriquer un médicament destiné à traiter les infections au staphylococcus aureus chez la vache
US5124145A (en) * 1989-10-24 1992-06-23 Ciba-Geigy Canada Ltd. Method for the prevention and treatment of bovine mastitis
ES2113354T3 (es) * 1990-05-04 1998-05-01 American Cyanamid Co Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina.

Also Published As

Publication number Publication date
NZ243850A (en) 1994-08-26
US5336488A (en) 1994-08-09
AU659179B2 (en) 1995-05-11
JPH06107560A (ja) 1994-04-19
EP0537437A3 (en) 1993-12-29
EP0537437A2 (fr) 1993-04-21
AU2085392A (en) 1993-02-11
HUT67071A (en) 1995-01-30
HU9202564D0 (en) 1992-10-28
ZA925909B (en) 1993-04-28
CA2075328A1 (fr) 1993-02-08
RU2078580C1 (ru) 1997-05-10

Similar Documents

Publication Publication Date Title
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
DE69233011D1 (de) Rekombinante antikörper zur humanen therapie
IT8619974A0 (it) Apparecchiatura per effettuare un idromassaggio avvolgente e continuo del corpo.
EP0505624A3 (en) Isocentric low turbulence injector
GB9204447D0 (en) Well treatment using ball sealers
IL77789A (en) Recombinant colony stimulating factor-1
EP0537437A3 (en) Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
EP0335704A3 (en) Treatment of equine livestock
DE69306768D1 (de) Medizinischer oder veterinaerer injektionsapparat
EP0589378A3 (fr) Cytokines glycosylées.
EP0299206A3 (en) Recombinant human adf
GB2260702B (en) Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
IL101749A0 (en) Treatment of mastitis
FI935850A0 (fi) Rening av rekombinant-apoliprotein E fraon bakterier
GB2245475B (en) Improvements in the treatment of animal feeds
HU914067D0 (en) New medical preparations for preventing gastric acid secretion and with gastrocitoprotective effect
SG67924A1 (en) Recombinant antibodies for human therapy
ZA892999B (en) Treatment of oestrus ovis infestations in sheep
IT1185763B (it) Tampone per prelievi in gola od altre parti del corpo umano con terreno di trasporto
IT1177074B (it) Tampone per prelievi in gola od altre parti del corpo umano con terreno di trasporto
ZA86839B (en) Recombinant colony stimulating factor-1
IT8323625V0 (it) Tampone per prelievi in gola od altre parti del corpo umano con terreno di trasporto.
ITFI910110A0 (it) Elettrocatetere per stimolazione e registrazione cardiaca
IT8423632V0 (it) Tampone per prelievi in gola od altre parti del corpo umano con terreno di trasporto.